FERI (Luxembourg) S.A.’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
FERI (Luxembourg) S.A.'s VRTX Position: Q3 2026 in Review
FERI (Luxembourg) S.A. increased its Vertex Pharmaceuticals (VRTX) stake by 83% in Q3 2026, buying an estimated $2.78M and bringing the position to 11,970 shares worth $6.26M. The position accounts for 0.84% of the portfolio, ranked #37.
FERI (Luxembourg) S.A. first reported a position in VRTX in Q4 2023 and has held it in 9 quarters since. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- FERI (Luxembourg) S.A. held 11,970 shares of Vertex Pharmaceuticals worth $6.26M as of Q3 2026.
- FERI (Luxembourg) S.A. bought 5,430 Vertex Pharmaceuticals shares in Q3 2026, an estimated $2.78M.
- Vertex Pharmaceuticals made up 0.84% of FERI (Luxembourg) S.A.'s portfolio in Q3 2026, its #37 holding.
- FERI (Luxembourg) S.A. first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.